Hermetica Superfood Encyclopedia
The Short Answer
Udombo contains phenols, flavonoids, triterpenoids (oleanolic acid, ursolic acid, lupeol), and alkaloids that inhibit acetylcholinesterase (IC50 0.55 mg/mL), butyrylcholinesterase (IC50 0.53 mg/mL), α-glucosidase (IC50 0.80 mg/mL), and α-amylase (IC50 1.65–1.69 mg/mL) in vitro. Preclinical antimicrobial assays demonstrate 16–21 mm zones of inhibition against tested pathogens using 10% stem and root extracts, though no human clinical trials have yet confirmed these effects in vivo.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordUdombo Achyranthes aspera benefits
Udombo — botanical close-up
Health Benefits
**Antidiabetic Support**
Dichloromethane and ethyl acetate extracts inhibit α-amylase (IC50 1.65–1.69 mg/mL) and α-glucosidase (IC50 0.80 mg/mL), slowing carbohydrate digestion and potentially blunting postprandial glucose spikes through enzyme competitive inhibition.
**Antioxidant Activity**: Total phenolic content of 28
86 mg GAE/g in infused extracts and 38.48 mg RE/g flavonoid content in DCM extracts contribute to free radical scavenging; methanolic extract DPPH IC50 is 135.8 µg/mL, indicating meaningful but moderate radical quenching capacity.
**Neuroprotective Potential**
Methanolic and DCM extracts inhibit acetylcholinesterase (AChE IC50 0.55 and 0.68 mg/mL respectively) and butyrylcholinesterase (BChE IC50 0.53–0.55 mg/mL), mechanisms relevant to cholinergic neurotransmission preservation in neurodegenerative conditions.
**Antimicrobial Effects**
Stem and root extracts at 10% concentration produce 16–21 mm zones of inhibition in agar diffusion assays, with lupeol and oleanolic acid hypothesized to disrupt microbial membrane integrity through triterpenoid intercalation.
**Anti-inflammatory Activity**: Oleanolic acid (0
54% in roots) and ursolic acid are well-characterized triterpenoids that inhibit NF-κB signaling and cyclooxygenase activity in preclinical models, supporting Udombo's traditional use in rheumatism and wound management.
**Anthelmintic and Diuretic Use**
Alkaloids, saponins, and glycosides present in high concentrations in seed and leaf extracts are proposed mediators of traditional anthelmintic and diuretic applications, consistent with documented use across Ayurvedic and African ethnomedicine.
**Wound Healing Support**
Network pharmacology analyses suggest polyphenol modulation of oxidative stress pathways, including Nrf2 activation by ferulic acid and caffeic acid identified via UHPLC-HRMS, which may accelerate tissue repair in topical applications.
Origin & History
Natural habitat
Achyranthes aspera is a pantropical weed native to Africa, Asia, and Australia, widely distributed across sub-Saharan Africa including Zimbabwe, where it grows in disturbed soils, roadsides, and forest margins at varying altitudes. In Zimbabwe it is commonly called Udombo and thrives in warm, semi-arid to humid conditions without deliberate cultivation, colonizing agricultural edges and homestead peripheries. The plant is harvested wild rather than farmed, with roots, seeds, stems, and leaves all utilized depending on the therapeutic application and regional tradition.
“Achyranthes aspera has been documented in Ayurvedic medicine texts for over two millennia, where it is known as Apamarga and prescribed for urinary disorders, bronchitis, rheumatism, and as a diuretic and anthelmintic, reflecting one of the broadest therapeutic profiles in classical Indian pharmacopoeia. In sub-Saharan Africa, including Zimbabwe where it is called Udombo, the plant holds a parallel role in traditional healing systems as a wound treatment, fever remedy, and antidiabetic aid, with knowledge transmitted through oral lineage among traditional healers (n'angas). Similar traditional applications are documented in Nigeria, Ghana, Kenya, and across Southeast Asia and the Pacific Islands, underscoring the plant's cross-cultural medicinal convergence independent of formal pharmacological understanding. Historical preparations across all traditions favor aqueous decoctions and infusions of roots and aerial parts, with seeds specifically used for anthelmintic purposes in several regional traditions.”Traditional Medicine
Scientific Research
Available evidence for Udombo (Achyranthes aspera) is entirely preclinical, comprising in vitro phytochemical characterization, enzyme inhibition assays, and microbiological disk diffusion studies with no published randomized controlled trials or observational cohort studies in humans. Phytochemical profiling studies using UHPLC-HRMS, GC-MS, and TLC have reliably identified key bioactives including lupeol, oleanolic acid, squalene, and phenolic acids across multiple research groups, lending reasonable confidence to compositional data. Functional assays report DPPH radical scavenging IC50 of 135.8 µg/mL for methanolic extract (compared to ascorbic acid reference at 11.1 µg/mL), enzyme inhibition IC50 values in the 0.53–1.69 mg/mL range, and antimicrobial zones of 16–21 mm, but these in vitro metrics do not directly translate to human efficacious doses without pharmacokinetic and bioavailability studies. The body of evidence is consistent with other Achyranthes species research internationally, but the absence of human trials, standardized extract preparations, and pharmacokinetic data represents a critical gap that limits clinical translation.
Preparation & Dosage
Traditional preparation
**Traditional Infusion (Tea)**
86 mg GAE/g) and is the primary form used in Zimbabwean folk medicine for fever, infections, and diabetes management
Whole plant aerial parts or roots steeped in hot water; this preparation yields the highest total phenolic content (28..
**Decoction**
Roots or stems simmered in water for 15–30 minutes; concentrates oleanolic acid and triterpenoid fractions; traditionally administered as 1–2 cups daily for rheumatic and antimicrobial indications.
**Methanolic/Ethanolic Extract (Research Grade)**
3 mg/mL; no standardized commercial extract or defined human dose exists; methanolic extracts yield broadest alkaloid, saponin, and flavonoid representation
Used in preclinical studies at .
**Ethyl Acetate Fraction**
Dominant flavonoid fraction used in research for cholinesterase and antidiabetic enzyme inhibition assays; not available as a consumer supplement.
**Root Powder**
Roots contain 0.54% oleanolic acid and 1.74% lupeol; traditionally ground and applied topically or taken internally; no validated oral dose established.
**Standardization**
No commercially standardized extract exists; research preparations are not standardized to a marker compound for consumer use.
**Timing Note**
Traditional use does not specify timing; antidiabetic applications would logically align with pre-meal administration based on α-amylase/α-glucosidase inhibition mechanisms.
Nutritional Profile
Achyranthes aspera leaves and seeds contain appreciable concentrations of phenolic acids (total phenolics 28.86 mg GAE/g in infusion; 9.9 µg/mL gallic acid equivalents in methanolic extract), flavonoids (total flavonoid content 38.48 mg RE/g in DCM extract), and structurally diverse triterpenoids including lupeol (1.74%), oleanolic acid (0.54% in roots), ursolic acid, and squalene (0.55%). Fatty acid constituents include 9,12-octadecadienoic acid ester (1.12%) identified via GC-MS, alongside tetradecane (0.62%) and other lipid-soluble compounds. High concentrations of alkaloids, saponins, tannins, terpenoids, steroids, and glycosides are consistently reported in seed and leaf methanolic and ethanolic extracts, while acylquinic acids and hydroxycinnamic acids (ferulic, caffeic) are present in polar fractions. Bioavailability of these compounds in humans is unstudied; lipophilic triterpenoids typically require micellarization for intestinal absorption, while polyphenols are subject to extensive first-pass metabolism and colonic biotransformation.
How It Works
Mechanism of Action
Phenolic acids including ferulic acid and caffeic acid, identified via UHPLC-HRMS, donate hydrogen atoms to neutralize reactive oxygen species and activate Nrf2-mediated antioxidant gene expression, while flavonoids chelate transition metals to interrupt Fenton-type oxidative chain reactions. Triterpenoids oleanolic acid and ursolic acid suppress pro-inflammatory cytokine production through NF-κB pathway inhibition, and lupeol (1.74% concentration) disrupts microbial membrane phospholipid bilayers, accounting for observed antimicrobial zones of inhibition. Methanolic and DCM extracts competitively inhibit cholinesterases (AChE and BChE IC50 0.53–0.68 mg/mL), preserving synaptic acetylcholine levels through reversible active-site occlusion by polyphenolic constituents. α-Amylase and α-glucosidase inhibition by DCM and ethyl acetate fractions (IC50 1.65–1.69 mg/mL and 0.80 mg/mL respectively) reduces intestinal glucose liberation, with saponins and acylquinic acids proposed as principal carbohydrase-inhibiting agents based on structural docking analyses.
Clinical Evidence
No human clinical trials investigating Udombo or Achyranthes aspera extracts with defined sample sizes, control arms, or statistically powered endpoints have been identified in the peer-reviewed literature. All quantified outcomes derive from in vitro enzymatic assays, DPPH radical scavenging models, and agar diffusion antimicrobial tests conducted at preclinical concentrations (e.g., 3 mg/mL for activity testing). While these preclinical results are internally consistent and mechanistically plausible, effect sizes cannot be extrapolated to human supplemental doses without bioavailability data, and confidence in clinical outcomes remains very low. Formal phase I safety and pharmacokinetic trials would be a necessary prerequisite before any therapeutic dosing recommendations could be issued.
Safety & Interactions
No adverse effects have been reported in the preclinical studies reviewed, and traditional use across multiple cultures over centuries suggests reasonable tolerability at typical decoction quantities; however, formal human toxicology studies including maximum tolerated dose, LD50 in humans, or chronic safety data are absent. The documented inhibition of acetylcholinesterase and butyrylcholinesterase (IC50 0.53–0.68 mg/mL) raises a theoretical interaction risk with prescribed cholinesterase inhibitors such as donepezil, rivastigmine, or galantamine used in Alzheimer's disease management, potentially causing additive cholinergic excess. α-Glucosidase and α-amylase inhibitory activity suggests caution when combining Udombo preparations with antidiabetic medications including metformin, acarbose, or insulin, as additive glucose-lowering effects could increase hypoglycemia risk. Pregnancy and lactation safety is unstudied; the presence of potent alkaloids, saponins, and uterotonic triterpenoids characteristic of the Achyranthes genus warrants avoidance during pregnancy until human safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Achyranthes asperaApamargaPrickly chaff flowerDevil's horsewhipChirchita
Frequently Asked Questions
What is Udombo used for in Zimbabwean traditional medicine?
In Zimbabwe, Udombo (Achyranthes aspera) is traditionally used by healers to manage fever, wounds, rheumatic pain, diabetes, and intestinal worms. Roots and aerial parts are most commonly prepared as decoctions or infusions and administered orally or topically depending on the condition being treated.
Does Achyranthes aspera lower blood sugar?
Preclinical in vitro studies show that DCM and ethyl acetate extracts of Achyranthes aspera inhibit α-amylase (IC50 1.65–1.69 mg/mL) and α-glucosidase (IC50 0.80 mg/mL), enzymes responsible for dietary carbohydrate digestion, which could reduce postprandial glucose absorption. However, no human clinical trials have confirmed blood sugar lowering effects, so it cannot currently be recommended as an antidiabetic treatment.
Is Udombo safe to take with diabetes medications?
Udombo preparations may theoretically enhance the glucose-lowering effects of antidiabetic drugs such as acarbose, metformin, or insulin due to overlapping α-glucosidase and α-amylase inhibitory mechanisms, potentially increasing hypoglycemia risk. No human drug interaction studies exist, so concurrent use with antidiabetic medications should only occur under medical supervision.
What are the active compounds in Achyranthes aspera?
Key bioactive compounds identified via UHPLC-HRMS and GC-MS include the triterpenoids lupeol (1.74%), oleanolic acid (0.54% in roots), ursolic acid, and squalene (0.55%), alongside phenolic acids such as ferulic acid and caffeic acid, flavonoids, alkaloids, saponins, and fatty acids including 9,12-octadecadienoic acid ester (1.12%). The relative abundance of these compounds varies significantly depending on the plant part used and the extraction solvent employed.
Are there any clinical trials on Achyranthes aspera in humans?
As of current literature, no published randomized controlled trials or observational human studies with defined sample sizes and clinical endpoints have investigated Achyranthes aspera. All available efficacy data derives from in vitro enzyme assays, DPPH radical scavenging tests, and agar diffusion antimicrobial studies, giving the evidence base a preliminary classification and an evidence score of 4 out of 10.
What is the difference between Achyranthes aspera leaf extracts and whole plant preparations?
Leaf extracts of Achyranthes aspera typically concentrate active compounds like flavonoids and phenolics, achieving higher bioactive concentrations (38.48 mg RE/g flavonoid content) compared to whole plant infusions. Whole plant preparations may provide additional compounds from stems and roots but with lower overall potency of α-amylase and α-glucosidase inhibitory activity. The choice between extract and whole plant depends on whether maximum enzyme-inhibiting activity or broader phytochemical diversity is the goal.
Who should avoid taking Udombo supplements?
Individuals with severe kidney or liver disease should exercise caution, as safety data specifically for these populations remains limited. Pregnant and nursing women should consult healthcare providers before use, as traditional medicine applications do not guarantee safety in these contexts. Those already taking multiple antidiabetic medications should avoid Udombo without medical supervision due to potential additive glucose-lowering effects.
How do different extraction methods affect the antidiabetic potency of Achyranthes aspera?
Dichloromethane and ethyl acetate extracts demonstrate superior α-glucosidase inhibition (IC50 0.80 mg/mL) compared to water-based infusions, suggesting organic solvent extraction concentrates the most bioactive compounds. Aqueous extractions still retain meaningful phenolic content (28.86 mg GAE/g) but with reduced enzyme inhibitory efficiency. The extraction method directly impacts the final product's carbohydrate-digestion-slowing capacity and should be considered when selecting Udombo preparations.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w udombo-achyranthes-aspera curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
